DES(2-METHYLBUTANOYL)-2-METHYLPENTANOYL PRAVASTATIN
UNII N107O289NP

Substance Identification & Data

This profile provides standardized clinical and technical data for Des(2-methylbutanoyl)-2-methylpentanoyl Pravastatin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N107O289NP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 159345-66-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N107O289NP
CAS Registry Number
159345-66-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DES(2-METHYLBUTANOYL)-2-METHYLPENTANOYL PRAVASTATIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C24H38O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QARPWNSGRMMWII-SJINMKGWSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(C[C@@H](C[C@@H](CC[C@H]1[C@H](C=CC2=C[C@H](C[C@@H]([C@]12[H])OC([C@H](CCC)C)=O)O)C)O)O)(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Des(2-methylbutanoyl)-2-methylpentanoyl Pravastatin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DES(2-METHYLBUTANOYL)-2-METHYLPENTANOYL PRAVASTATIN
PRAVASTATIN SODIUM IMPURITY C [EP IMPURITY]
PRAVASTATIN SODIUM IMPURITY, PENTANOYL IMPURITY- [USP IMPURITY]

Systematic Nomenclature

(3R,5R)-3,5-DIHYDROXY-7-((1S,2S,6S,8S,8AR)-6-HYDROXY2-METHYL-8-(((2S)-2-METHYLPENTANOYL)OXY)-1,2,6,7,8,8AHEXAHYDRONAPHTHALEN-1-YL)HEPTANOIC ACID
(3R,5R)-3,5-DIHYDROXY-7-((1S,2S,6S,8S,8AR)-6-HYDROXY-2-METHYL-8-(((2S)-2-METHYLPENTANOYL)OXY)-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)HEPTANOIC ACID
1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,.DELTA.,6-TRIHYDROXY-2-METHYL-8-(((2S)-2-METHYL-1-OXOPENTYL)OXY)-, (.BETA.R,.DELTA.R,1S,2S,6S,8S,8AR)-
1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,.DELTA.,6-TRIHYDROXY-2-METHYL-8-((2-METHYL-1-OXOPENTYL)OXY)-, (1.ALPHA.(.BETA.S*,.DELTA.S*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.)-(+)-
HOMOPRAVASTATIN